This article is sponsored by CAS. Jacob Al-Saleem, PhD, Senior Data Scientist at CAS, explains why it is important to take a data-first approach when building predictive models for drug discovery. Since the early 2000s, big tech companies have been compiling and analysing user data to not only track behaviour but also to predict it. […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!